CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,614
- in 3 filings
Net −$395,614. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-14 | Wilson Martin General Counsel | Other acquisition | +16,947 | 66,810 | ||
| 2023-02-14 | Wilson Martin General Counsel | Other disposition · Restricted Stock Units | −16,947 | 0 | ||
| 2023-02-14 | Patel Kinnari See Remarks | Other acquisition | +38,735 | 405,018 | ||
| 2023-02-14 | Patel Kinnari See Remarks | Other disposition · Restricted Stock Units | −38,735 | 0 | ||
| 2023-02-14 | Militello John See Remarks | Other acquisition | +11,067 | 57,729 | ||
| 2023-02-14 | Militello John See Remarks | Other acquisition · Restricted Stock Units | +11,067 | 0 | ||
| 2023-02-14 | Schwartz Jonathan David See Remarks | Option exercise | +8,574 | 98,103 | ||
| 2023-02-14 | Schwartz Jonathan David See Remarks | Grant or award · Stock Option (Right to Buy) | +124,496 | 124,496 | ||
| 2023-02-14 | Schwartz Jonathan David See Remarks | Grant or award · Restricted Stock Units | +41,541 | 41,541 | ||
| 2023-02-14 | Schwartz Jonathan David See Remarks | Option exercise · Restricted Stock Units | +8,574 | 17,410 | ||
| 2023-02-14 | Patel Kinnari See Remarks | Option exercise | +15,720 | 166,566 | ||
| 2023-02-14 | Patel Kinnari See Remarks | Grant or award · Stock Option (Right to Buy) | +199,194 | 199,194 | ||
| 2023-02-14 | Patel Kinnari See Remarks | Grant or award · Restricted Stock Units | +66,467 | 66,467 | ||
| 2023-02-14 | Patel Kinnari See Remarks | Option exercise · Restricted Stock Units | +15,720 | 31,917 | ||
| 2023-02-14 | Militello John See Remarks | Option exercise | +2,858 | 2,858 | ||
| 2023-02-14 | Militello John See Remarks | Grant or award · Stock Option (Right to Buy) | +49,798 | 49,798 | ||
| 2023-02-14 | Militello John See Remarks | Grant or award · Restricted Stock Units | +16,616 | 16,616 | ||
| 2023-02-14 | Militello John See Remarks | Option exercise · Restricted Stock Units | +2,858 | 5,803 | ||
| 2023-02-14 | Shah Gaurav CEO | Option exercise | +31,440 | 549,079 | ||
| 2023-02-14 | Shah Gaurav CEO | Grant or award · Stock Option (Right to Buy) | +348,590 | 348,590 |
Page 17 of 19 · 374 trades